Annals of Military and Health Sciences Research

Published by: Kowsar

CYP1A1 Gene Polymorphism and Breast Cancer

Sahar Balkhi 1 , * and Farhad Mashayekhi 2
Authors Information
1 Faculty of Sciences, University of Guilan, Islamic Azad University Rasht Branch, Guilan, IR Iran
2 Faculty of Sciences, University of Guilan, Guilan, Iran
Article information
  • Annals of Military and Health Sciences Research: June 2017, 15 (2); e63399
  • Published Online: June 30, 2017
  • Article Type: Original Article
  • Received: April 3, 2017
  • Revised: May 15, 2017
  • Accepted: June 2, 2017
  • DOI: 10.5812/amh.63399

To Cite: Balkhi S, Mashayekhi F. CYP1A1 Gene Polymorphism and Breast Cancer, Ann Mil Health Sci Res. 2017 ; 15(2):e63399. doi: 10.5812/amh.63399.

Abstract
Copyright © 2017, Annals of Military and Health Sciences Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Li W, Liu KJ, Song JS, Song R, Liu ZL. Association between RAD51 polymorphism and breast cancer susceptibility: a meta analysis. Int J Clin Exp Med. 2015;8(2):2326-33. [PubMed: 25932169].
  • 2. Rodrigues MS, Machado CA, Pagnoncelli D, Avvad E, Paixao JC, Gallo CV. TP53 and XRCC1 polymorphisms and breast cancer prognosis: a case-case study. Clinics (Sao Paulo). 2011;66(6):1097-100. [PubMed: 21808882].
  • 3. Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB, et al. Variation in the RAD51 gene and familial breast cancer. Breast Cancer Res. 2006;8(3):R26. doi: 10.1186/bcr1415. [PubMed: 16762046].
  • 4. Sapkota Y, Mackey JR, Lai R, Franco-Villalobos C, Lupichuk S, Robson PJ, et al. Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One. 2014;8(6). e64896. doi: 10.1371/journal.pone.0064896. [PubMed: 23755158].
  • 5. Basham VM, Pharoah PD, Healey CS, Luben RN, Day NE, Easton DF, et al. Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis. 2001;22(11):1797-800. [PubMed: 11698341].
  • 6. Miyoshi Y, Takahashi Y, Egawa C, Noguchi S. Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women. Breast J. 2002;8(4):209-15. [PubMed: 12100112].
  • 7. Sergentanis TN, Economopoulos KP. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;122(2):459-69. doi: 10.1007/s10549-009-0694-5. [PubMed: 20035380].
  • 8. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, et al. Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J. 2010;35(1):152-9. doi: 10.1183/09031936.00120808. [PubMed: 19608585].
  • 9. Germain D. Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin North Am. 2011;40(3):473-84. vii. doi: 10.1016/j.ecl.2011.05.009. [PubMed: 21889715].
  • 10. Li M, Li YY, Xin XY, Han Y, Wu TT, Wang HB. Quantitative assessment of the association between CYP1A1 A4889G polymorphism and endometrial cancer risk. Tumour Biol. 2013;34(6):3675-80. doi: 10.1007/s13277-013-0949-y. [PubMed: 23860774].
  • 11. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and ovarian cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(11):9921-30. doi: 10.1007/s11033-012-1860-0. [PubMed: 22733497].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments